NF1 and malignant peripheral nerve sheath tumor: The rationale being that if an NF1-deficient MPNST responds to a particular inhibitor while a sporadic MPNST does not, the effect may be attributed specifically to NF1 loss, rather than to features common to all MPNSTs.